Skin defects significantly affect quality of life and can pose a substantial physical and social handicap for millions of people. At Linio Biotech, we are redefining skin regeneration through our proprietary innovation in novel advanced cell-free tissue technology.
Location: Finland, Mainland Finland, Helsinki
Employees: 11-50
Total raised: $4.58M
Founded date: 2017
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.11.2023 | - | $4.58M | - |
Mentions in press and media 4
| Date | Title | Description |
| 23.11.2023 | Linio Biotech raises €4.2M for tissue regeneration skincare | This week sees Finnish biotech growth company Linio Biotech raise €4.2 million, bringing its funding to over €9 million. Spun out from the University of Tampere by its founding partners Timo Ylikomi, professor of cell biology, and cell biol... |
| 22.11.2023 | Finnish company Linio Biotech raises €4.2M investment round | Finnish company Linio Biotech raises €4.2M investment round 22 November, 2023, 13:55 Rostyslav Sobachynskyi --> --> --> -->--> --> --> --> --> --> --> --> --> Helsinki-based biotech growth company L... |
| 10.10.2023 | NextCell signs an agreement for a new tissue product | NextCell signs an agreement for a new tissue product Tue, Oct 10, 2023 13:00 CET Report this content NextCell Pharma AB (“NextCell” or “the company”) announces that the company has signed an agreement with the Finnish biotechnology company ... |
| - | Linio Biotech Ltd | “Science by nature, Inspired by biology, driven by curiosity. We redefine skin regeneration.” |